These pathophysiologic mechanisms—especially reduced erythropoietin synthesis and iron deficiency represent the two principal contributors to anemia in CKD, and form the clinical foundation for our study's diagnostic focus. This evidence concerns the gene EPO and Iron deficiency anemia.